EUthyroid2: the Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe

Launched by EUTHYROID · Jan 8, 2025

Keywords

ClinConnect Summary

This clinical trial, called EUthyroid2, is focused on addressing iodine deficiency, which can lead to health problems, especially in young women. The study aims to raise awareness about the risks of iodine deficiency among women aged 18 to 24 living in Norway, Poland, the UK, Bangladesh, and Pakistan. Researchers will develop and test new strategies in healthcare settings to help improve knowledge and understanding of iodine's importance, and they will gather feedback through surveys and interviews with participants and healthcare professionals.

To be eligible for this trial, participants must be non-pregnant women aged 18 to 24 who are able to understand the study information and consent forms. They should also be attending the specified healthcare settings. Women with thyroid diseases, those who are pregnant or breastfeeding, will not be able to participate. If you join the study, you can expect to take part in discussions and activities designed to help you learn more about iodine and its importance for health, while also contributing to efforts to improve awareness in your community.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • non-pregnant Female
• • Age 18-24 years at the time point of recruitment
• • Attending the specified settings
• • Sufficient language skills to understand the study information, informed consent and the questionnaire
• Exclusion Criteria:
• • Having a thyroid disease
• • Pregnancy at the timepoint of recruitment and during the intervention period
• • Lactation